L
Leonardo A. Sechi
Researcher at University of Udine
Publications - 173
Citations - 7102
Leonardo A. Sechi is an academic researcher from University of Udine. The author has contributed to research in topics: Blood pressure & Essential hypertension. The author has an hindex of 42, co-authored 153 publications receiving 6342 citations. Previous affiliations of Leonardo A. Sechi include University of Graz & San Francisco General Hospital.
Papers
More filters
Journal ArticleDOI
Expression of AT2 receptors in the developing rat fetus.
TL;DR: The transient expression of AT2 receptors in the mesenchyme of the fetus suggests a role of angiotensin II in fetal development.
Journal ArticleDOI
Cardiovascular outcomes in patients with primary aldosteronism after treatment.
Cristiana Catena,GianLuca Colussi,Elisa Nadalini,Alessandra Chiuch,Sara Baroselli,Roberta Lapenna,Leonardo A. Sechi +6 more
TL;DR: Primary aldosteronism is associated with a cardiovascular complication rate out of proportion to blood pressure levels that benefits substantially from surgical and medical treatment in the long term.
Journal ArticleDOI
Long-term Renal Outcomes in Patients With Primary Aldosteronism
Leonardo A. Sechi,Marileda Novello,Roberta Lapenna,Sara Baroselli,Elisa Nadalini,GianLuca Colussi,Cristiana Catena +6 more
TL;DR: In the majority of patients in this study, primary aldosteronism was characterized by partially reversible renal dysfunction in which elevated albuminuria is a marker of a dynamic rather than structural renal defect.
Journal ArticleDOI
Long-Term Cardiac Effects of Adrenalectomy or Mineralocorticoid Antagonists in Patients With Primary Aldosteronism
Cristiana Catena,GianLuca Colussi,Roberta Lapenna,Elisa Nadalini,Alessandra Chiuch,Pasquale Gianfagna,Leonardo A. Sechi +6 more
TL;DR: In the long-term, both adrenalectomy and spironolactone are effective in reducing left ventricular mass in patients with primary aldosteronism, with effects that are partially independent of blood pressure changes.
Journal ArticleDOI
Plasma adiponectin is decreased in nonalcoholic fatty liver disease.
Claudio Pagano,Giorgio Soardo,Walter Esposito,Francesco Fallo,Lorenza Basan,D. Donnini,Giovanni Federspil,Leonardo A. Sechi,Roberto Vettor +8 more
TL;DR: Data support a role for low circulating adiponectin in the pathogenesis of NAFLD and confirm the strict association between reduced adiponECTin production by adipose tissue, NAFLd and insulin resistance.